[2 cases of thorotrastosis]

Area of Science:

• Radiology
• Pathology
• Medical History

Background:

• Thorotrast, a radioactive contrast agent, was used medically until the 1950s.
• Long-term retention of Thorotrast in the body can lead to serious health consequences.
• Thorotrastosis is a recognized but often overlooked delayed complication.

Observation:

• Two patients presented with thorotrastosis that was not suspected by them.
• Clinical presentation can be insidious, lacking obvious initial symptoms.
• Diagnostic challenges arise due to the latent nature of the disease.

Findings:

• The reported cases highlight the persistent risk associated with past Thorotrast exposure.
• Pathological understanding is key to identifying subtle diagnostic clues.
• Early detection is essential for managing potential sequelae.

Implications:

• Increased awareness of thorotrastosis is needed among healthcare professionals.
• Understanding the disease's pathology aids in timely diagnosis and appropriate patient management.
• Fulfilling medicolegal requirements necessitates accurate documentation and diagnosis of thorotrastosis.